June 2, 2022
Immunotherapy unleashes the immune system to fight cancer, but it doesn’t work for all patients, and newly reported research may help to explain why. The study, headed by a team at Weill Cornell Medicine, indicates that the genetic program of T lymphocyte immune cells infiltrating malignant tumors, and the developmental path that these T cells then follow, may affect their response to immunotherapy and predict overall patient survival. Read More